INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 105 filers reported holding INFINITY PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $90,000 | -3.2% | 17,082 | +44.5% | 0.00% | 0.0% |
| Q4 2015 | $93,000 | -64.5% | 11,819 | -61.9% | 0.00% | -66.7% |
| Q3 2015 | $262,000 | +43.2% | 31,039 | +85.2% | 0.01% | +71.4% |
| Q2 2015 | $183,000 | -47.1% | 16,756 | -18.3% | 0.01% | -41.7% |
| Q4 2014 | $346,000 | +109.7% | 20,502 | +48.1% | 0.01% | +200.0% |
| Q1 2014 | $165,000 | -34.8% | 13,841 | -24.5% | 0.00% | -42.9% |
| Q4 2013 | $253,000 | – | 18,344 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 17,426,968 | $36,945,000 | 1.45% |
| Opaleye Management Inc. | 3,171,800 | $6,724,000 | 0.88% |
| EAM Investors, LLC | 421,103 | $893,000 | 0.15% |
| Bleichroeder LP | 250,000 | $530,000 | 0.10% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 755,593 | $1,602,000 | 0.04% |
| Callan Capital, LLC | 73,200 | $155,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 419,300 | $889,000 | 0.02% |
| Private Wealth Advisors, Inc. | 12,000 | $25,000 | 0.01% |
| Alpine Global Management, LLC | 24,575 | $52,000 | 0.01% |
| Evercore Wealth Management, LLC | 143,138 | $303,000 | 0.01% |